Abstract Notch signaling is an evolutionarily conserved mechanism that plays a critical role in the determination of multiple cellular differentiation pathways and morphogenesis during embryogenesis. The limb bud high-density culture is an established model that recapitulates mesenchymal condensation and chondrocyte differentiation. Reverse transcription-polymerase chain reaction (RT-PCR) showed that Notch and its related genes were expressed in such cultures on day 1 and reached a peak between day 3 and day 5, when cell condensation and nodule formation were initiated. Immunohistochemical experiments revealed that the expression of Notch1 was initially localized within the nodules and shifted to their peripheral region as the cell differentiation progressed. We disrupted Notch signaling by using a gamma-secretase inhibitor, N-[N-(3,5-difluorophenacetyl-l-alanyl)]-S-phenylglycine t-butyl ester (DAPT), to analyze the function of Notch signaling in the culture system. The blocking of Notch signaling by DAPT apparently promoted the initiation of prechondrogenic condensation and fusion of the nodules, and such an effect was reversed by exogenous expression of the Notch cytoplasmic domain. DAPT treatment also induced chondrogenic markers and bone morphogenetic protein (BMP)-related molecules, including type II collagen, Sox9, GDF5, and Id1. These observations imply that the Notch signal may have an important role in chondrogenic differentiation by negatively regulating the initiation of prechondrogenic condensation and nodule formation.
Introduction
Cartilage formation is a highly coordinated process involving the differentiation of chondrocytes and skeletal patterning. Endochondral bone formation, through which most of the long bones are created, is initiated by the aggregation of mesenchymal cells. Subsequently, these mesenchymal cells differentiate into chondrocytes, and the cartilage matrix produced by these cells is then calcified and replaced by bone in a subsequent step. In the past 20 years, a number of molecules that regulate the differentiation of chondrocytes have been identified. These molecules include cytokines and growth factors, such as bone morphogenetic proteins (BMPs), parathyroid hormone related protein (PTHrP), Indian hedgehog, and fibroblast growth factors, as well as some transcription factors, such as Sox9 and Cbfa1 [1] . However, the precise molecular mechanisms of the early onset of chondrogenesis have not been well defined, and other factors also seem to play roles in this process [2, 3] .
The early stage of chondrocyte differentiation is an event of patterning the skeletal components. In limb development, each skeletal component is formed through mesenchymal cell condensation, and the elongation, branching, and segmentation of these condensations [4] . Each primordial cartilage is kept separated from others by a joint cavity and surrounding mesenchymal tissues as their size grows. This process seems to be strictly controlled. Previous studies have shown that genes of the BMP families regulate this process. BMP signaling is one of the most powerful pathways to drive the differentiation of mesenchymal cells into chondrocytes [5, 6] . Mice overexpressing GDF5 in chondrocytes showed fused radii, ulnae, and metacarpals, in addition to fused synovial joints [7] . On the other hand, overexpression of noggin, an antagonist of BMP, caused a lack of most of the cartilaginous tissues [8] . These results suggest that BMP signaling is critically involved in the formation and growth of cartilage.
Notch signaling is involved in a wide array of developmental processes. The Notch signal is activated by interaction of the Notch receptor with other epidermal growth factor (EGF)-repeat-containing transmembrane ligands, such as Delta and Jagged. Ligand binding to Notch triggers proteolytic cleavage of the intracellular domain of Notch (Notch-IC) by presenilin [9] . Subsequently, Notch-IC is translocated into nuclei and associates there with a CBF-1/ Suppressor-of-Hairless/LAG-1 (CSL)-binding protein, RBP-J, leading to the activation of target genes such as those of the Hes and Herp families [10] . The involvement of Notch signaling molecules in the development of cartilaginous tissues is mainly suggested by the results of in vivo studies. In the developing chick embryo, the ectopic expression of exogenous Delta1 in limb cartilage blocked the maturation of chondrocytes, resulting in a malformation of limb cartilage, suggesting that Notch signals are involved in cartilage formation [11] . Presenilin1-deficient mice showed a significant defect in their vertebral bones [12] . In such mice, these bones were underossified, and a significant part of the bones consisted of an unsegmented cartilaginous mass, suggesting that Notch signaling is involved in the transition from cartilage to bone tissue, as well as in the segmentation of vertebral bones. A similar defect in the axial skeleton was also reported in human spondylocostal dysostosis, in which mutations were found in DLL3, a human Delta homologue gene [13] . The fact that Serrate2 was mutated in mouse limb mutant syndactylism, as well as the deformation of craniofacial and limb cartilages in Jagged2 knockout mice, also points to specific roles for these genes in cartilage morphogenesis [14, 15] . These studies suggested roles of Notch signaling in several steps of chondrocytes differentiation; however, the molecular mechanism is largely unknown. Therefore, defined in-vitro experimental systems would seem to be effective methods for elucidating the specific roles of Notch at each step of chondrocyte cell differentiation. Watanabe et al. [16] previously evaluated the role of Notch in one of the defined chondrogenic cell differentiation models. In their study, adenovirus-mediated expression of Notch-IC in chondrogenic ATDC5 cells strongly suppressed both the proliferation and early differentiation of these chondrocytes [16] . However, a gain-offunction study using a single type of cell culture system may not be sufficient for drawing a conclusion about the functional role of genes.
The limb bud micromass culture is another culture system using either chicken or murine limb bud mesenchymal cells, which was originally established to examine early events of limb chondrogenesis in vitro [17] [18] [19] . In this culture system, mesenchymal cells, prepared from embryonic limb buds and plated at a high density, aggregate and form condensed nodules. Then, the mesenchymal cells inside these condensates differentiate into mature chondrocytes. Zhang et al. [20] examined the sequential expression of genes that characterize chondrocyte differentiation, and proved this system to be a reasonable model for analyses of the entire process of chondrogenic differentiation. In the present study, using such micromass cultures, we conducted a loss-of-function experiment, using a selective inhibitor of Notch signaling, to elucidate the roles of Notch in the early stage of chondrogenic nodule formation.
Materials and methods
Murine limb bud micromass culture and N-[N-(3,5-difluorophenacetyl-l-alanyl)]-S-phenylglycine t-butyl ester (DAPT) treatment
The distal quarter of limb buds from E12.5 C57BL6 mouse embryos was isolated and digested with 0.1% collagenase (Sigma Chemical, St. Louis, MO, USA) and 0.1% trypsin (Sigma) for 45 min in 5% CO 2 at 37°C. The dissociated cells were suspended and filtered through a nylon mesh (pore size 48 µm; Tokyo Screen, Tokyo, Japan) to generate a single-cell suspension, and were adjusted to 2 × 10 7 cells/ml in DMEM (Sigma) supplemented with 10% fetal bovine serum (FBS). Cell suspensions (20 µl drops) were placed in the center of each well of 12-well plates. After the cells had been allowed to attach for 90 min in 5% CO 2 at 37°C, they were then overlaid with 2 ml of DMEM supplemented with 10% FBS. The medium was replaced by fresh medium every other day. A 100-µM portion of DAPT (Calbiochem, Darmstadt, Germany) was dissolved in dimethyl sulfoxide (DMSO) and diluted in the culture medium to a final concentration of 100 nM. Control cell cultures were treated with DMSO alone.
Alcian blue staining and morphometric analysis
Micromass cultures were fixed with 4% paraformaldehyde for 10 min and stained overnight with 1% alcian blue dye in 3% acetic acid at 37°C. The cultures were then digitally photographed with a stereomicroscope. The size and number of nodules were measured directly from the photographs. The alcian blue-stained area was quantified by making a binary image of the picture and calculating the ratio of the positive area to the total area, with NIH image software (Macintosh version 1.61; http://rsb.info.nih.gov/ nih-image/).
Western blotting
Cells were washed three times with phosphate-buffered saline (PBS) and scraped off the well surface. Nuclear and cytosolic proteins were extracted by using a Nuclear extraction kit (Chemicon International, Temecula, CA, USA) according to the manufacturer's instructions. Samples were subjected to sodium dodecylsulfate-polyacrylamide gel electrophoresis (SDS-PAGE), electroblotted onto an Immobilon membrane (Millipore, Billerica, MA, USA), and immunostained with the following antibodies. As primary antibodies, anti-cleaved Notch1 (Cell Signaling Technology, Beverly, MA, USA), anti-BMP4 (N-16; Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti-GDF5 (R&D System, Minneapolis, MN, USA), anti-Id1 (SantaCruz), and anti-α tubulin (H-300: SantaCruz) were used at dilutions of 1 : 1000, 1 : 100, 1 : 250, 1 : 200, and 1 : 200, respectively. Depending on the origin of the primary antibodies, one of the following secondary antibodies conjugated to horseradish peroxide (HRP) was used: goat anti-rat IgG (Amersham Bioscience, Piscataway, NJ, USA), rabbit antigoat IgG (Zymed Laboratories, Carlsbad, CA, USA), or donkey anti-rabbit IgG (Amersham Bioscience). Proteins in the blots were visualized by using an ECL plus kit (Amersham Bioscience).
Reverse-transcription-polymerase chain reaction analysis Total RNA was prepared by using ISOGEN (Nippon Gene, Toyama, Japan) according to the manufacturer's protocol. Four micrograms of total RNA was reverse transcribed into cDNA with oligo (dT) primer (Invitrogen, Carlsbad, CA, USA) and SuperScript II H-reverse transcriptase (Wako, Osaka, Japan). The cDNAs obtained were then subjected to semiquantitative PCR amplification. The primer sequences used for semiquantitative PCR were as follows: Presenilin1, 5′-ACA CCC CAT TCA CAG AAG ACA C-3′/5′-ATG GCA ATC ATC CCG ACC AC-3′(295 bp); Sox9, 5′-GTA GAT TGT TGG CGC CTT CC-3′/5′-GCA TTC CTT ATA CTC TCC AGC(503 bp); α1 type II collagen (Col2a1), 5′-CAG GAA GTA CCG GAG GCT CG-3′/5′-CAG GAT TGC CAT TAG CAC C-3′(309 bp); hypoxanthine-guanine phosphoribosyltransferase (HPRT), 5′-CTG GTG AAA AGG ACC TCT CG-3′/5′-TGA AGT ACT CAT TAT AGT CAA GGG C-3′(109 bp). The primers used for Notch1, Notch2, Notch3, Notch4, Delta1, Jagged1, and Jagged2 were described previously [21] . The number of PCR cycles (typically 25 to 35 cycles) was calibrated and determined for each primer set. For quantifying Hes1 expression, real-time PCR was performed. Using a Smart Cycler II (Takara Bio, Otsu, Japan), we amplified the reverse-transcribed cDNA with specific primers according to the manufacturer's instructions. The relative amount of mRNA was quantified by using a standard curve generated from cDNA dilution and normalized to HPRT as an internal control. The following primer sequences were used for the amplification of Hes1 cDNA: 5′-GTG AAG CAC CTC CGG AAC CT-3′/5′-AAG CGG GTC ACC TCG TTC AT-3′(119 bp).
Immunostaining of the cells
For immunocytostaining, limb bud mesenchymal cells were grown in two-well slides coated with collagen (Becton Dickinson, Franklin Lakes, NJ, USA). Streptavidinbiotin-peroxidase immunostaining was performed with a Vectastain Elite ABC Kit (Vector Laboratories, Burlingame, CA, USA). Cells were washed with PBS, and fixed with 4% paraformaldehyde in PBS for 5 min. Endogenous peroxidase activity was depleted by immersion for 30 min at −20°C in methanol containing 0.3% H 2 O 2. To minimize nonspecific binding, the specimens were incubated with 5% skimmed milk in 0.1% Tween 20-Tris buffered saline (TBS) for 1 h, and subsequently with anti-cleaved Notch 1 antibody (1 : 300 dilution) in 5% bovine serum albumin (BSA), 0.1% Tween 20 in TBS overnight at 4°C. Subsequently, the specimens were incubated with biotinylated goat antirabbit IgG (1 : 500 dilution; Vector Laboratories) for 1 h at room temperature, followed by ABC Reagent (Vector Laboratories) for 1 h at room temperature. Peroxidase activity was visualized by using a DAB substrate kit (Vector Laboratories).
For immunohistochemistry, cell cultures at 13 days were detached after fixation, embedded in Tissue-Tec OCT (Sakura Finetechnical, Tokyo, Japan), frozen in liquid nitrogen, and cryosectioned at a thickness of 8 µm. Immunostaining was performed as described above. The following antibodies were used: rabbit anti-mouse collagen type I (1 : 100 dilution; Calbiochem) as a primary antibody, biotinylated goat anti-rabbit IgG (1 : 500 dilution; Vector Laboratories) as a secondary antibody, and fluorescein isothiocyonate (FITC)-conjugated streptavidin fluorescein (1 : 150 dilution; eBioscience, San Diego, CA, USA) to visualize the immunoactivity.
Adenovirus vector
The adenovirus expression vector for enhanced green fluorescent protein and Notch-IC (EGFP-NIC) fusion protein was prepared as described previously [22] . Micromass cultures were infected with the viral vector 1 day after plating at a multiplicity of infection (m.o.i.) of approximately 100. Infection efficiency was quantified by flow cytometric analysis using a FACSCalibur (Becton Dickinson).
Results

Expression of Notch and its related genes in limb bud micromass cultures
In limb bud micromass cultures, cellular condensates were observed from 1 day after plating. The number of mesenchymal condensates increased gradually until day 5 of the culture period. Later, each condensate enlarged and differentiated into mature chondrocytes, as demonstrated morphologically and molecularly in a previous study [20] . We examined the expression of Notch-related genes in this culture system by using RT semiquantitative PCR. The expression of Notch1,2,3 and Notch ligands (Delta1 and Jagged1,2) increased with the mesenchymal condensation and each reached its highest level between day 3 and day 5 (Fig. 1) . Subsequently, the expression decreased, but trace levels of expression of Notch1, Notch2, Delta1, Jagged1, and Jagged2 were observed until day 14 of culture. Notch4 expression was not detected in this assay. Presenilin1, which is responsible for the catalytic activity of γ-secretase and cleaves the intracellular domain of Notch, was expressed constitutively. These data suggest that Notch and its related molecules are expressed from the initial stage of mesenchymal condensation, and are possibly involved in the differentiation process of chondrocytes.
Spatiotemporal localization of activated Notch1
Of the Notch family genes, Notch1 has been the one most widely studied [23, 24] . In previous studies, we investigated the involvement of Notch1 in osteoblastic and chondrogenic cell differentiation [16, 22] . For these reasons, we concentrated on Notch1 for further analysis. We examined the spatiotemporal localization of activated Notch1 by immunohistochemistry, using an antibody specific for the cleaved Notch1 molecule (Fig. 2) . This antibody recognizes the N-terminal epitope of the Notch1-intracellular domain (Val 1744 ), which is exposed by γ-secretase cleavage, and therefore, can detect only the active form of Notch1. Activated Notch1 was detected from day 1 ( Fig. 2A,B) . The staining was weak in general; however, a relatively strong signal seemed to be localized in the areas showing the early stage of cellular condensation. Even stronger staining was observed, localized in chondrogenic nodules, from day 5 to day 12 ( Fig. 2C-H) . Some positive cells were also observed in the internodular spaces. Interestingly, the peripheral region of each nodule seemed to be more strongly stained than the central region in the maturing nodules (Fig. 2F,H ).
DAPT enhances chondrogenic differentiation
Next, we treated the culture with DAPT to block Notch signaling to investigate its function in nodule formation. DAPT is a γ-secretase inhibitor, which blocks cleavage of the intracellular domain of all Notch proteins, and has been widely used in other systems [25] [26] [27] . Quantitative real-time PCR analysis demonstrated decreased expression of Hes1, which is a direct target gene of Notch signaling, in the DAPT-treated cultures (Fig. 3A) . In addition, Western blot analysis showed a significantly decreased level of cleaved Notch1 in these cultures compared with the control level (Fig. 3B) . These data indicate that Notch signaling was sufficiently blocked by DAPT in the current culture system. By day 3, mesenchymal condensation became more apparent in DAPT-treated cultures than in the control ones. Chondrogenic nodules in DAPT-treated cultures were markedly stained with alcian blue, indicating increased production of sulfated proteoglycan-rich chondrogenic matrix compared with the control cultures, on day 7 (Fig. 4A) . Molecules such as amyloid β-precursor, N-cadherin, ErbB4, and CD44 are also known substrates of γ-secretase, other than Notch [28] [29] [30] [31] . Therefore, DAPT treatment may affect these substrates in addition to Notch. So we transfected cells with the cDNA of Notch-IC with the aid of an adenovirus vector and confirmed that the effect of DAPT was counteracted by exogenous Notch-IC (Fig. 4A) . The alcian blue-stained area was approximately 2.5-fold increased by the DAPT treatment (Fig. 4B) . Both the size and the number of the nodules were markedly increased in DAPT-treated cultures; however, the increase in the number of nodules seemed to be more apparent than that in the size of them, suggesting that DAPT promoted the initiation of nodule formation rather than nodular growth (Fig. 4B) . As well, increased expression of Col2α1 and Sox9, differentiation markers of chondrocytes, in DAPT-treated cultures was confirmed by RT semiquantitative PCR (Fig. 4C) . Cell numbers were not significantly different between the control and DAPT-treated cultures, indicating that enhancement of chondrogenic differentiation in DAPT-treated culture was not due to the effect of increased cell proliferation (data not shown).
In DAPT-treated cultures on day 5, we observed cellular condensates and alcian blue-positive matrices in the internodular spaces (Fig. 5B,D) . In contrast, the alcian bluepositive areas were clearly restricted to the chondrogenic nodules in control cultures (Fig. 5A,C) . On day 12 in control cultures, each nodule was enlarged and eventually came into contact with neighboring nodules, but, generally, clear boundaries between the nodules were still maintained (Fig.  5E ). On the other hand, the boundary was less clear in DAPT-treated cultures; and each nodule had started to fuse with its neighbors (Fig. 5F ). Histological sections confirmed the fusion of neighboring nodules (Fig. 5G,H) . The periphery of the nodules and the internodular spaces were positive for type I collagen, and this area was significantly decreased in the DAPT-treated cultures (Fig. 5I,J) . These results indicate that Notch may act to suppress the differentiation of cells located in the periphery of the nodules and internodular spaces, preventing each nodule from fusion with neighboring nodules.
Effect of DAPT treatment on BMP signaling
Hatakeyama et al. [32] reported that BMP4 and GDF5 promoted chondrogenesis in limb bud micromass cultures. They observed that BMP4 induced chondrogenic differentiation in the internodular space, as we observed in our DAPT-treated cultures. Therefore, we examined the expression of BMP4 and GDF5 (Fig. 6 ). The expression of BMP4 was not changed by DAPT; however, that of GDF5 was markedly enhanced. The expression of Id1, a downstream target of canonical BMP signaling, was also considerably increased by the DAPT treatment.
Discussion
The molecular mechanisms involved in the regulation of the onset of cellular aggregation and subsequent chondrogenic differentiation are poorly understood [2, 3] . Several adhesion molecules are suggested to be involved in this step, such as N-cadherin and neural cell adhesion molecule (N-CAM) [33, 34] . These molecules may recruit mesenchymal cells to the center of the nodules. Conditional knockout of the transcription factor Sox9 in early limb bud proved that Sox9 was essential for this step [35] . Several reports suggest that BMPs, including their antagonist Noggin, are also essential to drive this initial step [5, 6] . We previously reported that overexpression of Notch-IC resulted in the loss of chondrogenic nodule formation in ATDC5 cells, suggesting that Notch-IC inhibits the differentiation of chondrocytes [16] . In the present study, the addition of DAPT to the culture system inhibited Notch signaling and enhanced chondrogenic differentiation. These complementary experiments enabled us to reinforce the hypothesis that Notch signaling suppresses chondrogenic differentiation.
Notch1 was expressed from the initial stage of chondrogenic nodule formation and was activated when and where the nodules were formed in limb bud micromass cultures. This result reminds us of our previous study, which showed that Notch1 expression was detected in aggregated mesenchymal cells in embryonic day (E)12.5 paws in developing [16] . The spatiotemporal expression in vitro and in vivo implies that Notch signaling functions at the early stage of cartilage tissue formation. But there seems to be a discrepancy as to why the active Notch was detected mainly in the differentiating nodules rather than in the internodular spaces. To explain this phenomenon, we propose a hypothesis, that Notch may function mainly in the periphery of the cartilaginous tissues, based on the following facts.
Inside the differentiating nodules, a large amount of matrix is produced by maturing chondrocytes, and these matrix proteins separate each cell from direct contact with its neighbor. The "lateral inhibition model" has been proposed to explain the action of Notch signaling in animal development [36] . In this model, Notch and its ligand act most effectively through direct contact between the cells. Therefore, the physical separation by extracellular matrix may interrupt Notch signaling from the neighboring cells and protect the maturing chondrocytes from the negative effect of Notch. Next, malfunction of Notch signaling molecules occasionally causes malformation of bone and cartilage tissues, characterized as the fusion of neighboring pieces of bones [12, 13] . The mechanism as to how the pri- Fig. 4 . Effect of DAPT on chondrocyte differentiation. A Alcian blue staining of micromass cultures on day 7. Cell cultures (control, DAPTtreated, and DAPT + Notch-IC transfected) were photographed with a stereomicroscope after staining. Transfection efficiency by adenovirus vector was 20%-30% by FACS analysis. Scale bar, 1 mm. B The staining intensity of alcian blue in day-7 cultures was quantified by using NIH image (n = 5). The number and diameter of the nodules were measured on the photographed pictures taken by phase-contrast microscopy. Measurement of the diameter (n = 30) and number (n = 5) of the nodules was performed on day-4 cultures, when each condensate was still visually isolated in the DAPT-treated cultures. The data were analyzed by Student's t-test, and the differences were statistically significant (P < 0.001). C The expression of Sox9 and Col2a1 was examined by semiquantitative RT-PCR. Total RNAs were harvested from day-3 cultures. HPRT was used as an internal control In the development of primordial cartilage, BMPs and related molecules also seem to play roles. Mice carrying a null mutation of Noggin, an antagonist of BMP, and mice overexpressing BMP4 or GDF5 in chondrocytes exhibited partially fused skeletal elements [5, 8] . In those mice, primordial cartilage anlagens, such as those of the radius, ulna, and digits were fused after excess cartilage growth. In the present study, we observed elevated expression levels of GDF5 and Id1 by blocking Notch signaling. At this point, we are not able to conclude that blocking Notch signaling by DAPT treatment induced the fusion of each nodule through the enhancement of BMP signaling; however, we speculate the existence of a cross-talk mechanism between the Notch and BMP signaling pathways, considering other reports. Both BMP and Notch signaling have crucial roles in cellular differentiation and embryonic morphogenesis. Generally, they act cooperatively, driving cellular fate in the same direction [37] [38] [39] ; however, an antagonistic effect has also been reported [40] . The cross-talk between the Notch and BMP signaling pathways is complicated and may show different profiles depending on the status of cellular differentiation. The precise mechanism regulating signaling integration between the Notch and BMP4 signaling pathways in chondrogenesis remains to be elucidated.
Using limb bud micromass cultures, we have demonstrated that Notch signaling inhibited the early differentiation of chondrocytes and regulated the formation of chondrogenic nodules. Future experiments should contribute to our better understanding of the functional roles of Notch signaling in the determination of the sizes and shapes of cartilage anlagens during embryonic development.
